Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07252687

The Effect of Gender-affirmative Measures on Breast Perception in Trans Men

Sponsor: Medical University Innsbruck

View on ClinicalTrials.gov

Summary

Breast dysphoria in transmasculine or genderdiverse individuals is a distinct psychological burden associated with depression, anxiety and suicidality. The aim is to systematically investigate the effect of GAHT (gender-affirming hormone therapy) and mastectomy on this form of dysphoria. The primary objective of this study is to analyse and investigate the psychological and physical effects of breast development on trans men or genderdiverse individuals. A secondary objective is to determine the extent to which the stress affects the well-being of trans men depending on the coping strategies used (binding vs. taping).

Official title: The Effect of Gender-affirmative Measures on Breast Perception in Trans Men (TRANSBREAST) - a Prospective Cohort Study

Key Details

Gender

FEMALE

Age Range

16 Years - Any

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2025-11-30

Completion Date

2030-11

Last Updated

2026-03-06

Healthy Volunteers

Not specified

Interventions

OTHER

quality of life questionnaire- iTransQoL, chest dysphoria measure

Before starting treatment, participants should complete the Chest Dysphoria Measure and iTransQoL questionnaires (=time point 0). The second time point for completing the questionnaires again is 3 months after starting hormone therapy. Subsequently, the questionnaires should be completed a third time after breast-affirming surgery. The final survey takes place two years after time point 0, or 6 months after the previous survey.

Locations (1)

Medical University Innsbruck

Innsbruck, Austria